Events & News
Valid Insight Are Attending The ISPOR Europe 2022
Valid Insight is excited to be attending the 2022 ISPOR Conference, to be held in November of this year. ISPOR – The Professional Society for Health Economics and Outcomes Research, is dedicated to improving global healthcare decisions. ISPOR holds that every healthcare decision should be informed by rigorous, and proven scientific methodologies. To support this, […]
Valid Insight Are Silver Sponsors At The World EPA Conference 2022
We are thrilled to be a Silver Sponsor for this year’s World Evidence, Pricing, and Access Congress (World EPA Congress). The World EPA Congress provides cutting edge solutions and thought leadership from the brightest minds across the pharma and biotech industries. The World EPA Congress is the largest congress in market access, pricing, and evidence […]
Have You Taken Our Survey?
Have you taken our survey? Developing new, innovative therapies is both expensive and risky, to the extent that many treatments achieve marketing authorisation but not the commercial success required to cover their development costs. We want to understand your views about the challenges faced through a short survey – it only takes 3 minutes, we promise! […]
Webinar: What is the role of patient advocacy in market access and pricing?
Thursday 10th June 2021 at 2pm UK / 9am EST / 3pm CET.
Webinar: How has Brexit affected market access and pricing globally, and what else should we expect?
Thursday 13th May 2021 at 2pm UK / 9am EST / 3pm CET.
Webinar: How to achieve optimal market access for in vitro diagnostics and medical devices
Thursday 15th April 2021 at 2pm UK / 9am EST / 3pm CET.
Webinar: How to optimise the use of Patient Report Outcomes (PRO) in market access and pricing
Thursday 4th March 2021 at 2pm UK / 9am EST / 3pm CET.
ISPOR Europe 2020
Valid Insight are proud to be exhibiting at this year’s Annual ISPOR Europe 2020 Congress from 14th November to 18th November. Our team of Market Access, Pricing and HEOR experts will be available, throughout the event which will be held in Milan, Italy. If you would like to book a meeting with one of our […]
Virtual World Pharma Pricing, Market Access and Evidence Congress 2020
Valid Insight are proud to be sponsoring this year’s World Pharma Pricing, Market Access and Evidence Congress 2020 from 23rd to 25th September. Our team of market access and pricing consultants will be available at the event, giving a keynote presentation and chairing a roundtable discussion on important topics, and are providing free consultations at […]
ISPOR Annual Conference 2020
Valid Insight are proud to be exhibiting at next year’s Annual ISPOR 2020 Congress from 16th May to 20th May. Our team of Market Access, Pricing and HEOR experts will be available, throughout the event which will be held in Orlando, USA. If you would like to book a meeting with one of our experts, please contact us via discover@validinsight.com and […]
World Pharma Pricing, Market Access and Evidence Congress 2020
Valid Insight are proud to be exhibiting at next year’s World Pharma Pricing, Market Access and Evidence Congress 2020 from 18th March to 19th March. Our team of Market Access, Pricing and HEOR experts will be available, throughout the event which will be held at the Beurs van Berlage, Amsterdam, Netherlands. If you would like to book a […]
Webinar: Maintaining Market Access Continuity through a Global Pandemic
The global outbreak of coronavirus (COVID-19) and subsequent perception of public health risk creates challenges for international business continuity and market access planning. In this expert led round table, we bring together key industry stakeholders to share perspectives on some of the implications and consider solutions for how to mitigate the impact on your business […]
Advanced Course: Market Access Strategies by Raf De Wilde
Market access strategies involves the coherent actions of many functions in a pharmaceutical company. The market access function is therefore in a balancing act to find workable and acceptable solutions for pricing, positioning, and reimbursement that fit into the short- and long-term commercial objectives. This course, run by Valid Insight Senior Executive Advisor, Raf De […]
BIO-Europe 2019
Valid Insight are proud to be exhibiting at this year’s BIO-Europe 2019 from 11th November to 13th November. Our team of Market Access, Pricing and HEOR experts will be available, throughout the event which will be held at Hamburg Messe, Hamburg, Germany. If you would like to book a meeting with one of our experts, please contact us via discover@validinsight.com and […]
ISPOR 22nd Annual European Congress
For the fourth year in succession, we are excited and proud to be exhibiting at this year’s ISPOR 22nd Annual European Congress from 2nd November to 6th November, 2019. Our team of Market Access, Pricing and HEOR experts will be available throughout the event which will be held in Copenhagen, Denmark. If you would like to […]
9th Life Sciences EPP Pricing Forum
At Valid Insight, we continually look to be part of the important discussions on the trends and industry best-practices impacting pricing. Therefore, we are pleased to be attending the 9th Life Sciences EPP Pricing Forum in Munich from the 14th-16th of October. This year’s theme is pricing in a complex ecosystem – dealing with transparency, […]
World Pharma Pricing and Market Access Congress 2019
Valid Insight are proud to be exhibiting at this year’s World Pharma Pricing and Market Access Congress from 19th March to 20th March. Our team of Market Access, Pricing and HEOR experts will be available, throughout the event which will be held at the Beurs van Berlage, Amsterdam, Netherlands. If you would like to book a meeting with one of […]
PharmAccess Winter Leaders Forum 2018
Valid Insight, the global market access consulting company, are proud sponsors of the PharmAccess Winter Leaders 2018 Forum from 4th to 5th December in Berlin, Germany. Frank Cousins, Senior Director at Valid Insight, will be participating in a expert panel, on 4th December, entitled: Capability development for market access: Which competencies are needed in order […]
ISPOR 21st Annual European Congress
For the third year in succession, we are excited and proud to be exhibiting at this year’s ISPOR 21st Annual European Congress from 10th November to 14th November, 2018. Our team of Market Access, Pricing and HEOR experts will be available throughout the event which will be held at the Centre de Convencions Internacional, Barcelona, […]
PharmAccess Spring Leaders Forum 2018
Valid Insight are proud sponsors of the 10th PharmAccess Spring Leaders 2018 Forum from 17th to 18th April in London, UK. The PharmAccess Leaders Forum Spring is Europe’s strong benchmarking opportunity for senior-level Market Access Executives. This is the must-attend event for those looking to understand and develop best practice approaches to the vital and […]
World Pharma Pricing & Market Access Congress 2018
The Valid Insight team will be sponsoring and exhibiting at the 2018, World Pharma Pricing and Market Access conference at stand 22. At the conference, we will be bringing our world-first market access virtual reality experience. Where you will see what happens when the market access team is grilled by the Head of Marketing about […]
6th Orphan Drugs and Rare Diseases Global Congress 2018 Europe
We are excited and proud to be exhibiting at the 6th Orphan Drugs and Rare Diseases Global Congress 2018 Europe on 8th March and 9th March, 2017. Our team of Market Access, Pricing and HEOR experts will be available throughout the event which will be held at the Millennium Gloucester Hotel, London, UK. If you would like […]
Webinar: Brexit and pharma – what you should know
Join Managing Director, Dr Steve Bradshaw, as he participates in a webinar on the key topic of Brexit and pharma. The webinar is scheduled for 29th November, 3pm (UK time)/10am (EST): Register here One of the many questions that has arisen from the Brexit vote was how the move would impact the pharma sector, particularly with the […]
5th Symposium: Megatrends in Pharmaceutical Medicine
Valid Insight are very excited to have had a abstract accepted for the 5th Symposium on the Megatrends in Pharmaceutical Medicine. The poster will be presented at the conference and is on the topic of: Trends in outcomes-based pricing -challenges and opportunities in adoption. To learn more about how to leverage payer engagement and data capabilities to […]
ISPOR 20th Annual European Congress
For the second year in succession, we are excited and proud to be exhibiting at this year’s ISPOR 20th Annual European Congress from 4th November to 8th November, 2017. Our team of Market Access, Pricing and HEOR experts will be available throughout the event which will be held at the Scottish Event Campus (SEC), Glasgow, Scotland. If you would […]
Market Access for Cell & Gene Therapies 2017
Ensuring market access to transformative therapies by optimising pricing, reimbursement and real-world evidence strategies is important with the increase in the number of cell and gene therapies being developed, and coming to market, globally and the potential to revolutionise the treatment of disease. To this end, Managing Director, Steve Bradshaw will be chairing the keynote […]
Market Access Pricing & Reimbursement Global Congress 2017 Europe
Join the presentation by Valid Insight entitled: Biosimilar value communication: similar or innovative? The presentation will cover: The discussions on the regulatory and clinical requirements for biosimilars, as well as payers’ pricing expectations, but manufacturers must also remember the importance of value communication The essentials of value communication in market access, analyse some of the challenges […]
PharmAccess Spring Leaders Forum 2017
We are very excited to be sponsoring the 8th PharmAccess Spring Leaders 2017 Forum from 3rd May to 5th May, in Milan Italy.. Our team of Market Access and Real-World Evidence experts will be available throughout the event. If you would like to book a meeting, at the event, with one of our experts and learn more about how […]
Eyeforpharma Access Europe Summit 2017
Valid Insight are proud to be exhibiting at the 3rd Annual Access Europe Summit 2017 from 25th April to 26th April. Our team of Market Access and Real-World Evidence experts will be available throughout the event at booth #1. If you would like to book a meeting, at the event, with one of our experts and learn more […]
Pharma Pricing and Market Access Europe 2017
Valid Insight are proud to be exhibiting at this year’s Pharma Pricing and Market Access Europe 2017 from 22nd February to 23rd February. Our team of Market Access and Real-World Evidence experts will be available, at booth #8, throughout the event which will be held at the Victoria Park Plaza, London. If you would like to book a […]
ISPOR 19th Annual European Congress
Valid Insight are proud to be exhibiting at this year’s ISPOR 19th Annual European Congress from the 29th October to 2nd November, 2016. Our team of Market Access and Real-World Evidence experts will be available, at booth 207, throughout the event which will be held at the Austria Center, Vienna. If you would like to book a meeting with […]
Webinar: Patient-reported outcomes in clinical trials and studies
Attend our webinar with health outcomes expert Professor Crispin Jenkinson, Senior Associate at Valid Insight, for an overview of patient-reported outcomes and applications from clinical trials to the routine assessment of services and in the economic evaluation of healthcare. Patient-reported outcomes (PROs) include reports and ratings from patients on their health, functioning, and quality of life. […]
Webinar: Sustainable price competition – contradiction in terms?
Payers can boast great stories of successful price competition, caused by tendering and reimbursement negotiations. Attend this webinar by market access expert Raf De Wilde, Senior Advisor at Valid Insight, to learn: why companies fall into the price competition trap what companies can do to alleviate price competition what the consequences are for market access […]
Market Access, Pricing and Reimbursement 2016 Europe
In June 2016, Valid Insight participated in the two-day Market Access, Pricing and Reimbursement 2016 Europe conference, which provided a platform to discuss market access, pricing and reimbursement issues facing our industry. To understand how Valid Insight can support market access, pricing and reimbursement challenges you face – do not hesitate to contact the team at discover@validinsight.com.
PharmAccess Spring Leaders Forum 2016
We were really proud to sponsor the PharmAccess Leaders Forum which took place in London in April 2016. At the conference, Managing Director, Dr Steve Bradshaw took part in a panel discussion discussing medical innovation in times of budget pressure. To get more funding insights do not hesitate to contact the team at discover@validinsight.com.
We Are Joining the Bioscript Group
Valid Insight are delighted to announce that we are joining the Bioscript group. Valid Insight will be the latest addition to the Bioscript Group as they extend their services in global market access consulting and payer value communications. We are looking forward to the exciting journey ahead and to building our partnership with Bioscript. Valid […]
Announcing the launch of Valid Insight
Dr Steve Bradshaw, leading a team of key life science advisors and market access experts, has launched Valid Insight, a new market access consultancy created to help companies navigate the challenges faced by drug developers seeking market access for new and innovative therapeutics. Getting a new drug to market and to patients who need better medicines […]
Raf De Wilde delivers a masterclass for MSc students in Germany
As part of our corporate responsibility to bring new talent in to the industry, our Senior Executive Advisor, Raf De Wilde, will be returning to the University of Duisburg-Essen to deliver a one-day masterclass on patient-reported outcomes and real-world evidence for students studying a Master of Science (MSc) in Pharmaceutical Medicine. We look forward to […]
We are recruiting
As a rapidly growing pharma market access consultancy, Valid Insight are looking for high calibre senior individuals to join us on our journey. If you are passionate about market access, with demonstrable knowledge and experience in delivering international projects that make a difference, we’d love to hear from you. To learn more about what we […]
The Valid Insight visit to Buckingham Palace
In April, it was announced that the Valid Insight team had been awarded the Queen’s Award for Enterprise in International Trade. It was an amazing moment for us all. It was not only a testament to the team’s hard work and indisputable expertise, but to our clients’ trust in us to help them to keep […]
Inside the Valid Insight Queen’s Award Ceremony
In April this year, Valid Insight were awarded the Queen’s Award for Enterprise in International Trade 2019 – the UK’s most esteemed business award, given only to those companies who have demonstrated outstanding results in their field and achieved significant growth and success over three years. Winning this award is invaluable to our team and […]
Valid Insight welcomes Frank Cousins as Senior Director
Valid Insight, the specialist global market access consultancy, are excited to announce that we have appointed Frank Cousins as Senior Director. Frank has over 20 years’ experience as a consultant to the pharmaceutical industry, specialising in the integration of regulatory strategy, evidence generation and market access for optimal launch and commercial planning. Frank Cousins will […]
Valid Insight, market access company, wins Queen’s Award for Enterprise 2019
In October 2019, Valid Insight received the Queen’s Award for Enterprise in International Trade – recognised globally as one of the highest accolades for business success. Our video captures the best moments from the award ceremony. Watch it here:
We’re going from strength to strength – want to join us?
Current vacancies: Director, Market Access & Pricing Principal Consultant, Market Access & Pricing Senior Market Access & Payer Research Consultant Location: Europe-wide As a rapidly growing Pharma Market Access Consultancy, Valid Insight are looking for high calibre senior individuals to join us on our journey. If you are passionate about Market Access, with demonstrable knowledge […]
Valid Insight joins the Scottish Life Sciences Association
Valid Insight, a specialist global market access consultancy firm with Europe based staff, including London, Belgium and Scotland, has joined the Scottish Lifesciences Association, in order to develop its role in life sciences in the region’s hubs, and to support the fast-growing local industry. “SLA is the voice of Scotland’s vibrant life sciences industries to […]
Valid Insight Queen’s Award presentation: recognising a market access company
Take a look at the very moment that one of the most esteemed business awards, the Queen’s Award for Enterprise in International Trade 2019, was presented to our team.
Rattling the tins: Valid Insight collects donations for Leuka
Leukaemia is the 12th most common cancer in Europe, and the 11th most common worldwide. Leuka is a specialist leukaemia charity (now part of Leukaemia UK), investing in the next generation of leukaemia research talent in the UK and beyond. In 2017, Leuka raised nearly £1 million for research, and awarded £2.2 million to blood […]
Expert insights into pharmaceutical pricing and market access
Valid Insight’s Senior Executive Advisor, Raf De Wilde, has over 40 years’ experience in the pharmaceutical industry and over 30 years’ experience in global market access. Watch our video as he shares his expert insights in pharmaceutical pricing and market access:
Discover Valid Insight: a global market access company
From years of experience in market access and the pharmaceutical industry, to our trusted client partnerships, we share our insights into what we believe has led to the team’s success and growth over the years.
Valid Insight’s new appointments confirm its strength in market access and value
LONDON, UK – Just 18 months after its February 2016 launch, market access consultancy Valid Insight is pleased to announce the appointment of two new senior people to its rapidly expanding team. Dominic Jones-Phillips and James Wright bring decades of specialist experience from industry. Dominic Jones-Phillips and James Wright will lead global pricing, reimbursement, and […]
Press Release: Valid Insight wins the Queen’s Most Coveted Award for Enterprise
The Queen’s Awards for Enterprise are the UK’s most esteemed business awards, presented only to the most eminent of companies or individuals, demonstrating outstanding results in their field. Today, Her Majesty the Queen announced approval of the Prime Minister’s recommendation for Valid Insight to be honoured in recognition of the outstanding success of the company’s […]
Valid Insight to contribute to Advanced Master’s in Biotechnology & Pharmaceutical Management programme
At Valid Insight, we’re pleased to announce that in May 2020, we’ll be providing a series of specialist Market Access lectures as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a leading French graduate business school. Thanks to our TRAVELLESS™ solution, our trusted virtual platform that we […]
Using TRAVELLESS™ to provide tailored pharmaceutical training
In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry. With […]
Carolyn Steeds featured in the 2nd Edition of Medical Writing in HEOR/Market Access Guide
The second edition of the medical writing in HEOR/Market Access careers guide was launched in June 2019. This guide focuses on medical writing roles in the HEOR/market access arenas, but will be of interest to anyone who wants to understand more about the business of ensuring access to new medicines and devices for patients. If you have […]